Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)
China · Delayed Price · Currency is CNY 6.57
-0.19 (-2.81%)
Sep 18, 2025, 2:45 PM CST
SHA:600222 Revenue
Henan Taloph Pharmaceutical Stock Co.,Ltd had revenue of 439.16M CNY in the quarter ending June 30, 2025, with 2.57% growth. This brings the company's revenue in the last twelve months to 1.78B, down -11.31% year-over-year. In the year 2024, Henan Taloph Pharmaceutical Stock Co.,Ltd had annual revenue of 1.94B, down -6.21%.
Revenue (ttm)
1.78B
Revenue Growth
-11.31%
P/S Ratio
2.10
Revenue / Employee
802.44K
Employees
2,214
Market Cap
3.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.94B | -128.49M | -6.21% |
| Dec 31, 2023 | 2.07B | 109.21M | 5.57% |
| Dec 31, 2022 | 1.96B | 356.18M | 22.20% |
| Dec 31, 2021 | 1.60B | 187.42M | 13.23% |
| Dec 31, 2020 | 1.42B | 105.28M | 8.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| WuXi AppTec | 41.90B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Shanghai United Imaging Healthcare | 10.98B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.94B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |